Jincheng Pharmaceutical: Expected net profit attributable to parent company in the first quarter to grow by 51.19%—85.42% year-on-year

2026-04-10 04:16:19

People’s Financial News, April 8 — Jincheng Pharmaceutical (300233) announced its earnings forecast on April 8, expecting a net profit attributable to shareholders of 53 million to 65 million yuan in the first quarter, a year-on-year increase of 51.19% to 85.42%. During the reporting period, the company’s intermediate products segment saw increased sales of some products compared to the same period last year, and capacity utilization improved.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.